Biomarkers of Immune Activation and Incident Kidney Failure With Replacement Therapy: Findings From the African American Study of Kidney Disease and Hypertension.
Am J Kidney Dis
; 78(1): 75-84.e1, 2021 07.
Article
en En
| MEDLINE
| ID: mdl-33388403
Palabras clave
APOL1 risk variant; African American; CKD progression; IFN-γ; TNF-α; apolipoprotein L1 gene (APOL1); biomarkers; chronic kidney disease (CKD); death; end-stage kidney disease (ESKD); immune activation; kidney failure; mortality; risk stratification; sTNFR1; sTNFR2; soluble urokinase-type plasminogen activator receptor; suPAR
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Insuficiencia Renal
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Kidney Dis
Año:
2021
Tipo del documento:
Article